ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AMPH Amphastar Pharmaceuticals Inc

44.625
1.11 (2.54%)
Last Updated: 10:11:02
Delayed by 15 minutes

Period:

Draw Mode:

Volume 28,393
Bid Price 44.60
Ask Price 44.68
News -
Day High 44.66

Low
35.62

52 Week Range

High
67.66

Day Low 43.76
Company Name Stock Ticker Symbol Market Type
Amphastar Pharmaceuticals Inc AMPH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.11 2.54% 44.625 10:11:02
Open Price Low Price High Price Close Price Prev Close
43.76 43.76 44.66 43.52
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
528 28,393 $ 44.04 $ 1,250,341 - 35.62 - 67.66
Last Trade Time Type Quantity Stock Price Currency
10:11:07 10 $ 44.6462 USD

Amphastar Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.09B 48.10M - 644.4M 137.55M 2.86 15.22
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Amphastar Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AMPH Message Board. Create One! See More Posts on AMPH Message Board See More Message Board Posts

Historical AMPH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week44.2844.7942.83543.69339,2860.3450.78%
1 Month49.8150.3542.1645.08548,771-5.19-10.41%
3 Months61.6665.924942.1651.35492,639-17.04-27.63%
6 Months46.6165.924942.1652.45448,537-1.99-4.26%
1 Year37.6467.6635.6250.80450,1776.9918.56%
3 Years18.3167.6616.9138.55347,41926.32143.72%
5 Years20.5867.6612.32532.68296,41724.05116.84%

Amphastar Pharmaceuticals Description

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Your Recent History

Delayed Upgrade Clock